Trumpas laikotarpisVidutinis laikotarpisIlgas laikotarpisSignalai

SELLAS Life Sciences [SLS]

Birža: NASDAQ
Sektorius: Healthcare
Pramonė: Biotechnology
Paskutinį kartą atnaujinta 22 Jun 2026 @ 10:08 (Exchange is open)
Paskutinė: $0 0.00%
0.61 (↑)
GaG Algo Score™
v1.0
Trumpas
0.61 (↑)
Vidutinis
2.50 (↑)
Ilgas
1.94 (↑)
PIRKTI
59.18%
grąža 32.32%
PARDUOTI
64.00%
grąža -26.16%

Statistika

Šiandienos apimtis 0
Vidutinė apimtis 0
Rinkos kapitalizacija 1.15B
EPS $-0.0487 (Q1 | 2026-05-12)
Kita rezultatų data ($-0.0500) 2026-08-11
Paskutinis dividendas $0.420 (2010-12-09)
ATR14 $0.669 (8.31%)
Galimas dienos svyravimas $7.72 - $8.38 (8.67%)

Palaikymo ir pasipriešinimo lygiai

Linija

Pivot duomenys

Pivot statistika
Rodiklis Vidurkis Mediana Stand. nuokr.
Prieaugis % 50.50% 30.17% 51.20%
Nuostolis % -18.88% -18.88% 6.11%
Trukmė 16.0d 12d 11.5d
Rasta pivot taškų 6
Prieaugio/nuostolio atkarpos 5 (3 Prieaugis / 2 Nuostolis)
Paskutinis pivot Top @ $8.05 data 2026-06-18
Pokytis nuo paskutinio pivot $0.00 (0.00%)
Kito pivot prognozė Paskutinė: $0.00
Prognozuojamas kitas tipas Bottom
Prognozuojama kaina (vid.) $6.53
Prognozuojama kaina (mediana) $6.53
Prognozuojamas kainos intervalas (~68%) $6.04 - $7.02
Pokytis iki vidutinio tikslo $6.53 (N/A)
Prognozuojama data (vid.) 2026-07-04
Prognozuojamas datos intervalas (~68%) 2026-06-22 - 2026-07-15
Pagrindas Based on 2 historical losses (Avg: -18.88%, Median: -18.88%, StdDev of Abs: 6.11%) and duration (Avg: 16.0 days, StdDev: 11.5 days)
Pastaba Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Significant gain for SELLAS Life Sciences, up 3.74%.

SELLAS Life Sciences (SLS) stock price soared on Thursday after the stock rose $0.290 (3.74%) from the previous session on very high volume. The stock moderately outperformed the market today, rising faster than the NASDAQ's 1.91% gain. Yesterday's trading volume was 14.75M shares, worth about $118.72M. This represents 10.07M shares more than the day before. Volume was above the 10-day average of 5.98M shares.

SELLAS Life Sciences signals

There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (16.7%), medium- (16.7%), and long-term (16.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

SELLAS Life Sciences Support & Resistance Levels

The stock is approaching the closest resistance level at $8.33. approximately $0.280 (3.48%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $8.97. On a fall back there will be support at $6.53 The dis das resistance s16.53 -

SELLAS Life Sciences Evaluation

  • Trumpas balas: 0.61
  • Vidutinis balas: 2.50
  • Ilgas balas: 1.94